coderm-research-logo380px

CODerm Research:  303.761.0906

(option 6)

Active Clinic Trials

psoriasis-ad

(1) Psoriasis

Do you or someone you know suffer from moderate to severe plaque psoriasis? Are you 18+ and at least 198 pounds?

You may qualify for a clinical research trial studying how effective an investigational medication is for moderate-to-severe plaque psoriasis in heavier individuals.

Qualified participants:

  • Will receive study-related care from a board certified physician and other medical staff at no cost
  • Reimbursement available for time and travel
abbvie-eczema-ad

(2) Atopic Dermatitis (Eczema)

Eczema doesn’t have to control your life. If you are struggling with the symptoms of moderate to severe atopic dermatitis, a study involving a once daily oral pill in combination with topical corticosteroids could be an option for you.

Qualified participants include:

  • Adolescents and adults aged 12 to 75 years (minimum weight of 88 pounds)
  • Those with chronic moderate to severe symptoms that started at least 3 years from planned study start date
  • No prior Dupixent usage

Those that qualify will:

  • Receive study-related care from a board certified physician and other medical staff at no cost
  • Receive payment for each visit
Clinical Trial for Atopic Dermatitis Eczema

(3) Atopic Dermatitis (Eczema)

Do you suffer from moderate to severe Atopic Dermatitis (Eczema)?  If so, you may qualify for a clinical trial studying the effectiveness of a once daily investigational oral pill for moderate to severe atopic dermatitis.

Qualified participants include:

  • Adults aged 18 and up

Those that qualify will:

  • Receive study treatment from a board certified dermatologist at no cost
  • Will be compensated for their time, per visit

Interested in participating in a clinical trial?

Please contact us at (303) 761-0906, option 6 or email us at cr@coloradodermatology.com with your name, phone number, date of birth and study of interest.

Sponsors

If you are interested in having CODerm running your study at our site please contact research@coloradodermatology.com.